Exton, PA, United States of America

Sylvie Laquerre


Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 50(Granted Patents)


Location History:

  • Walnut Creek, CA (US) (2003)
  • Danville, CA (US) (2004)
  • Conshohocken, PA (US) (2006 - 2008)
  • Chesterbrook, PA (US) (2014)
  • Exton, PA (US) (2006 - 2015)

Company Filing History:


Years Active: 2003-2015

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Sylvie Laquerre: Innovator in Pharmaceutical Compositions

Introduction

Sylvie Laquerre is a prominent inventor based in Exton, PA, known for her significant contributions to the field of pharmaceutical compositions. With a total of 10 patents to her name, she has made remarkable advancements in the treatment of viral infections.

Latest Patents

Laquerre's latest patents include innovative compounds and methods for treating hemorrhagic fever viruses. These patents focus on sulfonyl semicarbazides, semicarbazides, and ureas, along with pharmaceutical compositions designed to combat infections associated with arenaviruses. Her work discloses methods for preparing these compounds and their therapeutic applications, particularly in treating viral infections caused by various families of viruses, including Arenaviridae, Filoviridae, Flaviviridae, and Bunyaviridae. Additionally, she has developed compounds and methods for preventing pneumovirus infections and associated diseases.

Career Highlights

Throughout her career, Laquerre has worked with notable companies such as Onyx Pharmaceuticals, Inc. and Siga Technologies Inc. Her expertise in pharmaceutical research has led to significant advancements in the treatment of viral diseases.

Collaborations

Laquerre has collaborated with esteemed colleagues, including Terry Hermiston and Yuqiao Shen, contributing to her innovative research and development efforts.

Conclusion

Sylvie Laquerre's work in pharmaceutical compositions and her dedication to combating viral infections highlight her as a key figure in the field of innovation. Her contributions continue to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…